Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Regeneron Pharmaceuticals
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
United States, Japan, Puerto Rico, South Korea
Sponsor: Cascade Pharmaceuticals, Inc
Primary Biliary Cholangitis
China
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Australia, Brazil, Bulgaria +24 more
Sponsor: Chiesi Farmaceutici S.p.A.
Asthma
China
Sponsor: China-Japan Friendship Hospital
Emphysema
China
Sponsor: Eli Lilly and Company
Type 2 Diabetes Mellitus
United States, Argentina, Australia, Austria, Belgium +26 more
- Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant GliomaActive Not Recruiting
Sponsor: Institut de Recherches Internationales Servier
IDH1-mutant Glioma · IDH2-mutant Glioma
United States, Austria, China, France, Germany +6 more
- Early Onset Colorectal Cancer DetectionRecruiting
Sponsor: City of Hope Medical Center
Colorectal Cancer · Colorectal Neoplasms · Colorectal Adenocarcinoma · Colorectal Cancer Stage I
United States, Italy, Japan, Spain
- Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder CancerActive Not Recruiting
Sponsor: AstraZeneca
Non-muscle-invasive Bladder Cancer
Australia, Austria, Belgium, Canada, France +7 more
Sponsor: Bayer
Advanced Solid Tumors
United States, Belgium, China, Japan, South Korea +2 more
- PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric CancerActive Not Recruiting
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Gastric or Esophagogastric Junction Adenocarcinoma
China
Sponsor: Bayer
Advanced Metastatic Castration-resistant Prostate Cancer · Prostate Specific Membrane Antigen (PSMA) Expression
United States, Belgium, Canada, Finland, Italy +5 more
- Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer PatientsActive Not Recruiting
Sponsor: AstraZeneca
Advanced Ovarian Cancer
United States, Austria, Belgium, Brazil, Bulgaria +15 more
- Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell LymphomaActive Not Recruiting
Sponsor: Duke University
Diffuse Large B Cell Lymphoma
United States, Czechia, Italy, Japan, Singapore +1 more
- A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye DiseaseActive Not Recruiting
Sponsor: Amgen
Thyroid Eye Disease
United States, Argentina, Australia, Canada, France +6 more
- A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung CancerActive Not Recruiting
Sponsor: Samsung Bioepis Co., Ltd.
Non-small Cell Lung Cancer Stage IV
Bosnia and Herzegovina, Brazil, Georgia, Germany, India +9 more
- A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Plaque Psoriasis
United States, Argentina, Australia, Brazil, Canada +8 more
Sponsor: Ono Pharmaceutical Co., Ltd.
Fibromyalgia
Japan
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)Completed
Sponsor: Novo Nordisk A/S
Early Alzheimer's Disease
United States, Argentina, Australia, Austria, Belgium +32 more
Sponsor: Bayer
Advanced Solid Tumors · HER2 Mutation
United States, Australia, Canada, China, Denmark +6 more
Sponsor: Ascendis Pharma Endocrinology Division A/S
Growth Hormone Deficiency · Endocrine System Diseases · Hormone Deficiency
United States, Armenia, Australia, Canada, Denmark +19 more
- A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe AsthmaActive Not Recruiting
Sponsor: Incyte Corporation
Moderate to Severe Asthma
United States, Argentina, Canada, Germany, Japan +2 more
Sponsor: Ascendis Pharma Endocrinology Division A/S
Adult Growth Hormone Deficiency · Endocrine System Diseases · Hormone Deficiency
United States, Armenia, Australia, Canada, France +16 more
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).Recruiting
Sponsor: Eli Lilly and Company
Alzheimer Disease · Dementia · Plaque, Amyloid
United States, Japan, Puerto Rico
- MDT-0123 Japan StudyRecruiting
Sponsor: Medtronic Spinal and Biologics
Disc Degeneration · Spinal Deformity
Japan